Compare Stocks

5 / 10
Try these comparisons:

Stock Comparison

FTEL vs NAUT vs CDNA vs XPOF vs PLNT

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
FTEL
Fitell Corporation

Specialty Retail

Consumer CyclicalNASDAQ • AU
Market Cap$791K
5Y Perf.-97.7%
NAUT
Nautilus Biotechnology, Inc.

Biotechnology

HealthcareNASDAQ • US
Market Cap$341M
5Y Perf.-25.1%
CDNA
CareDx, Inc

Medical - Diagnostics & Research

HealthcareNASDAQ • US
Market Cap$1.13B
5Y Perf.+101.5%
XPOF
Xponential Fitness, Inc.

Leisure

Consumer CyclicalNYSE • US
Market Cap$209M
5Y Perf.-80.3%
PLNT
Planet Fitness, Inc.

Leisure

Consumer CyclicalNYSE • US
Market Cap$3.66B
5Y Perf.+35.1%

FTEL vs NAUT vs CDNA vs XPOF vs PLNT — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
FTEL logoFTEL
NAUT logoNAUT
CDNA logoCDNA
XPOF logoXPOF
PLNT logoPLNT
IndustrySpecialty RetailBiotechnologyMedical - Diagnostics & ResearchLeisureLeisure
Market Cap$791K$341M$1.13B$209M$3.66B
Revenue (TTM)$9M$0.00$413M$299M$1.38B
Net Income (TTM)$-13M$-57M$-8M$-34M$229M
Gross Margin27.0%48.2%83.2%54.2%
Operating Margin-114.7%-3.3%7.8%29.6%
Forward P/E23.3x9.4x14.0x
Total Debt$580K$30M$20M$525M$443M
Cash & Equiv.$939K$12M$65M$34M$346M

FTEL vs NAUT vs CDNA vs XPOF vs PLNTLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

FTEL
NAUT
CDNA
XPOF
PLNT
StockAug 23Mar 26Return
Fitell Corporation (FTEL)1002.3-97.7%
Nautilus Biotechnol… (NAUT)10074.9-25.1%
CareDx, Inc (CDNA)100201.5+101.5%
Xponential Fitness,… (XPOF)10019.7-80.3%
Planet Fitness, Inc. (PLNT)100135.1+35.1%

Price return only. Dividends and distributions are not included.

Quick Verdict: FTEL vs NAUT vs CDNA vs XPOF vs PLNT

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: PLNT leads in 3 of 7 categories (5-stock set), making it the strongest pick for profitability and margin quality and capital preservation and lower volatility. Xponential Fitness, Inc. is the stronger pick specifically for valuation and capital efficiency and dividend income and shareholder returns. NAUT and CDNA also each lead in at least one category. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
FTEL
Fitell Corporation
The Defensive Pick

FTEL is the clearest fit if your priority is sleep-well-at-night.

  • Lower volatility, beta 1.19, Low D/E 6.4%, current ratio 4.22x
Best for: sleep-well-at-night
NAUT
Nautilus Biotechnology, Inc.
The Momentum Pick

NAUT ranks third and is worth considering specifically for momentum.

  • +275.1% vs FTEL's -78.7%
Best for: momentum
CDNA
CareDx, Inc
The Growth Leader

CDNA is the clearest fit if your priority is growth.

  • 13.8% revenue growth vs FTEL's -6.9%
Best for: growth
XPOF
Xponential Fitness, Inc.
The Income Pick

XPOF is the #2 pick in this set and the best alternative if income & stability is your priority.

  • Dividend streak 0 yrs, beta 1.79, yield 2.9%
  • Lower P/E (9.4x vs 14.0x)
  • 2.9% yield, vs PLNT's 0.0%, (3 stocks pay no dividend)
Best for: income & stability
PLNT
Planet Fitness, Inc.
The Growth Play

PLNT carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.

  • Rev growth 12.1%, EPS growth 31.0%, 3Y rev CAGR 12.2%
  • 215.8% 10Y total return vs CDNA's 393.7%
  • Beta 0.41, yield 0.0%, current ratio 2.11x
  • 16.5% margin vs FTEL's -141.4%
Best for: growth exposure and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthCDNA logoCDNA13.8% revenue growth vs FTEL's -6.9%
ValueXPOF logoXPOFLower P/E (9.4x vs 14.0x)
Quality / MarginsPLNT logoPLNT16.5% margin vs FTEL's -141.4%
Stability / SafetyPLNT logoPLNTBeta 0.41 vs XPOF's 1.79
DividendsXPOF logoXPOF2.9% yield, vs PLNT's 0.0%, (3 stocks pay no dividend)
Momentum (1Y)NAUT logoNAUT+275.1% vs FTEL's -78.7%
Efficiency (ROA)PLNT logoPLNT7.4% ROA vs FTEL's -126.4%, ROIC 35.2% vs -77.3%

FTEL vs NAUT vs CDNA vs XPOF vs PLNT — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

FTELFitell Corporation
FY 2024
Merchandise Revenue
0.0%$0
NAUTNautilus Biotechnology, Inc.

Segment breakdown not available.

CDNACareDx, Inc
FY 2025
Service
85.0%$274M
Product
15.0%$48M
XPOFXponential Fitness, Inc.
FY 2025
Franchise
50.7%$193M
Product
11.2%$42M
Franchise Marketing Fund Revenue
9.6%$36M
Equipment Revenue
9.2%$35M
Service, Other
7.1%$27M
Merchandise Revenue
6.3%$24M
Franchise And Service Revenue
5.9%$22M
PLNTPlanet Fitness, Inc.
FY 2025
Franchise
49.0%$381M
Equipment Revenue
39.9%$310M
Advertising
11.2%$87M

FTEL vs NAUT vs CDNA vs XPOF vs PLNT — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLPLNTLAGGINGXPOF

Income & Cash Flow (Last 12 Months)

PLNT leads this category, winning 3 of 6 comparable metrics.

PLNT and NAUT operate at a comparable scale, with $1.4B and $0 in trailing revenue. PLNT is the more profitable business, keeping 16.5% of every revenue dollar as net income compared to FTEL's -141.4%. On growth, CDNA holds the edge at +39.0% YoY revenue growth, suggesting stronger near-term business momentum.

MetricFTEL logoFTELFitell CorporationNAUT logoNAUTNautilus Biotechn…CDNA logoCDNACareDx, IncXPOF logoXPOFXponential Fitnes…PLNT logoPLNTPlanet Fitness, I…
RevenueTrailing 12 months$9M$0$413M$299M$1.4B
EBITDAEarnings before interest/tax-$10M-$58M$2M$35M$568M
Net IncomeAfter-tax profit-$13M-$57M-$8M-$34M$229M
Free Cash FlowCash after capex-$13M-$51M$65M-$3M$267M
Gross MarginGross profit ÷ Revenue+27.0%+48.2%+83.2%+54.2%
Operating MarginEBIT ÷ Revenue-114.7%-3.3%+7.8%+29.6%
Net MarginNet income ÷ Revenue-141.4%-2.0%-11.3%+16.5%
FCF MarginFCF ÷ Revenue-148.4%+15.8%-1.1%+19.3%
Rev. Growth (YoY)Latest quarter vs prior year+24.7%+39.0%-21.0%+21.9%
EPS Growth (YoY)Latest quarter vs prior year+67.8%+7.7%+126.3%+79.8%+30.0%
PLNT leads this category, winning 3 of 6 comparable metrics.

Valuation Metrics

Evenly matched — FTEL and XPOF each lead in 2 of 6 comparable metrics.

On an enterprise value basis, PLNT's 6.8x EV/EBITDA is more attractive than XPOF's 7.6x.

MetricFTEL logoFTELFitell CorporationNAUT logoNAUTNautilus Biotechn…CDNA logoCDNACareDx, IncXPOF logoXPOFXponential Fitnes…PLNT logoPLNTPlanet Fitness, I…
Market CapShares × price$791,005$341M$1.1B$209M$3.7B
Enterprise ValueMkt cap + debt − cash$432,344$358M$1.1B$700M$3.8B
Trailing P/EPrice ÷ TTM EPS-0.12x-5.70x-54.55x-3.81x17.51x
Forward P/EPrice ÷ next-FY EPS est.23.25x9.37x14.03x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple7.64x6.82x
Price / SalesMarket cap ÷ Revenue0.18x2.97x0.66x2.76x
Price / BookPrice ÷ Book value/share0.09x2.16x3.84x
Price / FCFMarket cap ÷ FCF31.21x8.45x14.36x
Evenly matched — FTEL and XPOF each lead in 2 of 6 comparable metrics.

Profitability & Efficiency

PLNT leads this category, winning 3 of 9 comparable metrics.

CDNA delivers a -2.6% return on equity — every $100 of shareholder capital generates $-3 in annual profit, vs $-169 for FTEL. FTEL carries lower financial leverage with a 0.06x debt-to-equity ratio, signaling a more conservative balance sheet compared to NAUT's 0.19x. On the Piotroski fundamental quality scale (0–9), PLNT scores 9/9 vs NAUT's 1/9, reflecting strong financial health.

MetricFTEL logoFTELFitell CorporationNAUT logoNAUTNautilus Biotechn…CDNA logoCDNACareDx, IncXPOF logoXPOFXponential Fitnes…PLNT logoPLNTPlanet Fitness, I…
ROE (TTM)Return on equity-169.3%-35.0%-2.6%
ROA (TTM)Return on assets-126.4%-29.2%-1.9%-9.5%+7.4%
ROICReturn on invested capital-77.3%-26.0%-5.7%+69.7%+35.2%
ROCEReturn on capital employed-98.5%-32.0%-5.8%+30.3%+14.2%
Piotroski ScoreFundamental quality 0–921559
Debt / EquityFinancial leverage0.06x0.19x0.06x
Net DebtTotal debt minus cash-$358,661$18M-$46M$491M$97M
Cash & Equiv.Liquid assets$939,014$12M$65M$34M$346M
Total DebtShort + long-term debt$580,353$30M$20M$525M$443M
Interest CoverageEBIT ÷ Interest expense-9.50x-0.05x6.73x
PLNT leads this category, winning 3 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

CDNA leads this category, winning 3 of 6 comparable metrics.

A $10,000 investment in PLNT five years ago would be worth $5,865 today (with dividends reinvested), compared to $466 for FTEL. Over the past 12 months, NAUT leads with a +275.1% total return vs FTEL's -78.7%. The 3-year compound annual growth rate (CAGR) favors CDNA at 38.5% vs FTEL's -64.0% — a key indicator of consistent wealth creation.

MetricFTEL logoFTELFitell CorporationNAUT logoNAUTNautilus Biotechn…CDNA logoCDNACareDx, IncXPOF logoXPOFXponential Fitnes…PLNT logoPLNTPlanet Fitness, I…
YTD ReturnYear-to-date+62.9%+40.3%+14.0%-30.2%-58.2%
1-Year ReturnPast 12 months-78.7%+275.1%+41.8%-35.6%-52.7%
3-Year ReturnCumulative with dividends-95.3%+12.6%+165.8%-80.6%-36.3%
5-Year ReturnCumulative with dividends-95.3%-73.4%-67.3%-54.3%-41.4%
10-Year ReturnCumulative with dividends-95.3%-74.3%+393.7%-54.3%+215.8%
CAGR (3Y)Annualised 3-year return-64.0%+4.0%+38.5%-42.2%-14.0%
CDNA leads this category, winning 3 of 6 comparable metrics.

Risk & Volatility

Evenly matched — CDNA and PLNT each lead in 1 of 2 comparable metrics.

PLNT is the less volatile stock with a 0.41 beta — it tends to amplify market swings less than XPOF's 1.79 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CDNA currently trades 93.9% from its 52-week high vs FTEL's 4.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricFTEL logoFTELFitell CorporationNAUT logoNAUTNautilus Biotechn…CDNA logoCDNACareDx, IncXPOF logoXPOFXponential Fitnes…PLNT logoPLNTPlanet Fitness, I…
Beta (5Y)Sensitivity to S&P 5001.19x1.77x1.36x1.79x0.41x
52-Week HighHighest price in past year$19.20$4.31$23.24$11.14$114.47
52-Week LowLowest price in past year$0.40$0.62$10.96$3.83$37.03
% of 52W HighCurrent price vs 52-week peak+4.7%+62.2%+93.9%+50.3%+40.1%
RSI (14)Momentum oscillator 0–10030.350.559.046.314.9
Avg Volume (50D)Average daily shares traded122K314K658K632K1.9M
Evenly matched — CDNA and PLNT each lead in 1 of 2 comparable metrics.

Analyst Outlook

Evenly matched — FTEL and XPOF each lead in 1 of 2 comparable metrics.

Analyst consensus: NAUT as "Buy", CDNA as "Buy", XPOF as "Buy", PLNT as "Buy". Consensus price targets imply 72.5% upside for PLNT (target: $79) vs -6.7% for NAUT (target: $3). XPOF is the only dividend payer here at 2.92% yield — a key consideration for income-focused portfolios.

MetricFTEL logoFTELFitell CorporationNAUT logoNAUTNautilus Biotechn…CDNA logoCDNACareDx, IncXPOF logoXPOFXponential Fitnes…PLNT logoPLNTPlanet Fitness, I…
Analyst RatingConsensus buy/hold/sellBuyBuyBuyBuy
Price TargetConsensus 12-month target$2.50$24.00$7.00$79.15
# AnalystsCovering analysts5131427
Dividend YieldAnnual dividend ÷ price+2.9%+0.0%
Dividend StreakConsecutive years of raises100
Dividend / ShareAnnual DPS$0.16$0.02
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%+7.8%0.0%+13.7%
Evenly matched — FTEL and XPOF each lead in 1 of 2 comparable metrics.
Key Takeaway

PLNT leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). CDNA leads in 1 (Total Returns). 3 tied.

Best OverallPlanet Fitness, Inc. (PLNT)Leads 2 of 6 categories
Loading custom metrics...

FTEL vs NAUT vs CDNA vs XPOF vs PLNT: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is FTEL or NAUT or CDNA or XPOF or PLNT a better buy right now?

For growth investors, CareDx, Inc (CDNA) is the stronger pick with 13.

8% revenue growth year-over-year, versus -6. 9% for Fitell Corporation (FTEL). Planet Fitness, Inc. (PLNT) offers the better valuation at 17. 5x trailing P/E (14. 0x forward), making it the more compelling value choice. Analysts rate Nautilus Biotechnology, Inc. (NAUT) a "Buy" — based on 5 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — FTEL or NAUT or CDNA or XPOF or PLNT?

On forward P/E, Xponential Fitness, Inc.

is actually cheaper at 9. 4x — notably different from the trailing picture, reflecting expected earnings growth.

03

Which is the better long-term investment — FTEL or NAUT or CDNA or XPOF or PLNT?

Over the past 5 years, Planet Fitness, Inc.

(PLNT) delivered a total return of -41. 4%, compared to -95. 3% for Fitell Corporation (FTEL). Over 10 years, the gap is even starker: CDNA returned +393. 7% versus FTEL's -95. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — FTEL or NAUT or CDNA or XPOF or PLNT?

By beta (market sensitivity over 5 years), Planet Fitness, Inc.

(PLNT) is the lower-risk stock at 0. 41β versus Xponential Fitness, Inc. 's 1. 79β — meaning XPOF is approximately 338% more volatile than PLNT relative to the S&P 500. On balance sheet safety, Fitell Corporation (FTEL) carries a lower debt/equity ratio of 6% versus 19% for Nautilus Biotechnology, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — FTEL or NAUT or CDNA or XPOF or PLNT?

By revenue growth (latest reported year), CareDx, Inc (CDNA) is pulling ahead at 13.

8% versus -6. 9% for Fitell Corporation (FTEL). On earnings-per-share growth, the picture is similar: Xponential Fitness, Inc. grew EPS 35. 2% year-over-year, compared to -228. 6% for Fitell Corporation. Over a 3-year CAGR, PLNT leads at 12. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — FTEL or NAUT or CDNA or XPOF or PLNT?

Planet Fitness, Inc.

(PLNT) is the more profitable company, earning 16. 5% net margin versus -208. 5% for Fitell Corporation — meaning it keeps 16. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PLNT leads at 29. 8% versus -179. 1% for FTEL. At the gross margin level — before operating expenses — PLNT leads at 82. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is FTEL or NAUT or CDNA or XPOF or PLNT more undervalued right now?

On forward earnings alone, Xponential Fitness, Inc.

(XPOF) trades at 9. 4x forward P/E versus 23. 3x for CareDx, Inc — 13. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for PLNT: 72. 5% to $79. 15.

08

Which pays a better dividend — FTEL or NAUT or CDNA or XPOF or PLNT?

In this comparison, XPOF (2.

9% yield) pays a dividend. FTEL, NAUT, CDNA, PLNT do not pay a meaningful dividend and should not be held primarily for income.

09

Is FTEL or NAUT or CDNA or XPOF or PLNT better for a retirement portfolio?

For long-horizon retirement investors, Planet Fitness, Inc.

(PLNT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 41), +215. 8% 10Y return). Nautilus Biotechnology, Inc. (NAUT) carries a higher beta of 1. 77 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (PLNT: +215. 8%, NAUT: -74. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between FTEL and NAUT and CDNA and XPOF and PLNT?

These companies operate in different sectors (FTEL (Consumer Cyclical) and NAUT (Healthcare) and CDNA (Healthcare) and XPOF (Consumer Cyclical) and PLNT (Consumer Cyclical)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: FTEL is a small-cap quality compounder stock; NAUT is a small-cap quality compounder stock; CDNA is a small-cap quality compounder stock; XPOF is a small-cap quality compounder stock; PLNT is a small-cap deep-value stock. XPOF pays a dividend while FTEL, NAUT, CDNA, PLNT do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

FTEL

High-Growth Disruptor

  • Sector: Consumer Cyclical
  • Market Cap > $100B
  • Revenue Growth > 12%
  • Gross Margin > 16%
Run This Screen
Stocks Like

NAUT

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
Run This Screen
Stocks Like

CDNA

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 19%
  • Gross Margin > 28%
Run This Screen
Stocks Like

XPOF

Income & Dividend Stock

  • Sector: Consumer Cyclical
  • Market Cap > $100B
  • Gross Margin > 49%
  • Dividend Yield > 1.1%
Run This Screen
Stocks Like

PLNT

High-Growth Compounder

  • Sector: Consumer Cyclical
  • Market Cap > $100B
  • Revenue Growth > 10%
  • Net Margin > 9%
Run This Screen

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.